BR102018071330A2 - water treatment composition - Google Patents
water treatment composition Download PDFInfo
- Publication number
- BR102018071330A2 BR102018071330A2 BR102018071330A BR102018071330A BR102018071330A2 BR 102018071330 A2 BR102018071330 A2 BR 102018071330A2 BR 102018071330 A BR102018071330 A BR 102018071330A BR 102018071330 A BR102018071330 A BR 102018071330A BR 102018071330 A2 BR102018071330 A2 BR 102018071330A2
- Authority
- BR
- Brazil
- Prior art keywords
- water treatment
- treatment composition
- support
- organic compound
- treatment component
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
- C02F1/54—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using organic material
- C02F1/56—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/10—Inorganic compounds
- C02F2101/20—Heavy metals or heavy metal compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/08—Seawater, e.g. for desalination
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/20—Nature of the water, waste water, sewage or sludge to be treated from animal husbandry
Abstract
uma composição para o tratamento da água compreendendo um componente de tratamento e um suporte em que o componente de tratamento é um composto orgânico líquido, e o suporte é um composto orgânico sólido.a water treatment composition comprising a treatment component and a support in which the treatment component is a liquid organic compound, and the support is a solid organic compound.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102018071330A BR102018071330A2 (en) | 2018-10-17 | 2018-10-17 | water treatment composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102018071330A BR102018071330A2 (en) | 2018-10-17 | 2018-10-17 | water treatment composition |
Publications (1)
Publication Number | Publication Date |
---|---|
BR102018071330A2 true BR102018071330A2 (en) | 2020-04-28 |
Family
ID=70547268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR102018071330A BR102018071330A2 (en) | 2018-10-17 | 2018-10-17 | water treatment composition |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR102018071330A2 (en) |
-
2018
- 2018-10-17 BR BR102018071330A patent/BR102018071330A2/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018004620A2 (en) | kras expression modulators | |
CL2018003135A1 (en) | Aromatic derivatives of sulfonamide. | |
BR112018073329A2 (en) | combination, pharmaceutical composition, kit, method for treating cancer, method for reducing a cell level, method for increasing activity, method for increasing cytotoxicity, method for reducing metastasis | |
CL2018000542A1 (en) | New phenoxymethyl derivatives. | |
CO2017013065A2 (en) | Diaciglycerol acyltransferase 2 modulators (dgat2) | |
CL2012003415A1 (en) | Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer. | |
ECSP21026021A (en) | PNPLA3 EXPRESSION MODULATORS | |
CL2008000202A1 (en) | Compounds derived from n-aryl-acetamide, trpv1 antagonist, pharmaceutical composition that comprises them, useful in the treatment of pain. | |
CL2015000976A1 (en) | Compounds of 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine for use in the treatment of diabetes and its associated disorders. | |
CL2016003074A1 (en) | Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer. | |
CL2016002497A1 (en) | "Compounds derived from substituted condensed heterocycles, modulators of gpr119; pharmaceutical composition comprising them; useful in the treatment of diabetes, obesity, dyslipidemia and related disorders ”. pct | |
CL2016002151A1 (en) | Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder | |
CR20190471A (en) | Modulators of pcsk9 expression | |
CL2017002214A1 (en) | Combination formulation of tesofensin and beta blocker | |
AR108148A1 (en) | METHODS TO COVER PACKING SURFACES WITH BENZOXABOROL COMPOUNDS TO PRESERVE FOOD FRESH | |
CL2015002113A1 (en) | Azetidinloxyphenylpyrrolidine compounds | |
BRPI0810762A8 (en) | COMPOSITION FOR WATER TREATMENT | |
CL2021001246A1 (en) | Irf5 expression modulators. | |
CO2020008769A2 (en) | Modulators of the dnm2 expression | |
UY38472A (en) | FOXP3 EXPRESSION MODULATORS | |
CO2020003134A2 (en) | Modulators of enac expression | |
CO2017001076A2 (en) | Antihyperalgesic, anti-allodinic and anti-inflammatory pharmaceutical compositions containing pregabalin and meloxicam | |
BR102018071330A2 (en) | water treatment composition | |
CU20170134A7 (en) | 2-THIOPIRIMIDINONES | |
BR112017001375A2 (en) | pharmaceutical agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |